News&Events

FDA Classifying RX and OTC Animal Drugs

Aug. 26, 2022

During the drug approval or indexing process, FDA is responsible for determining the marketing status (prescription, over-the-counter, or VFD) of animal drug products. To be sold over-the-counter (OTC), it must be possible to prepare "adequate directions for use" under which a layperson can use the drugs safely and effectively. Safe use includes safety to the animal, safety of food products derived from the animal, and safety to the persons associated with the animal.

Effective use of a drug product assumes that an accurate diagnosis can be made with a reasonable degree of certainty, that the drug can be properly administered, and that the course of the disease can be followed so that the success or lack of success of the product can be observed. Prescription (Rx) products can be dispensed only by or upon the lawful written order of a licensed veterinarian.

The same drug substances can be marketed in a number of different dosage forms, intended for use by different routes of administration, and in different species of animals. Thus, these drug products may be appropriately labeled Rx in some cases and OTC in others. Rx products must bear the legend:

"Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian." 


FDA Announces 2022 Public Meeting of the National Antimicrobial Resistance Monitoring System

plastic injection vial

FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs

30ml dial a dose syringe

FDA New Animal Drug Applications

PLASTIC LIQUID BOTTLE

Source from FDA

Contact Us

Mob.: +86 157 3193 8681

E-mail: [email protected]

whatsapp/wechat: +86 15731938681

QQ: 1536020095

Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights Reserved. | Sitemap | Technical Support 冀ICP备11016487号-1

wechat